-
1 Comment
CryoLife, Inc is currently in a long term uptrend where the price is trading 15.2% above its 200 day moving average.
From a valuation standpoint, the stock is 99.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.4.
CryoLife, Inc's total revenue sank by 2.6% to $68M since the same quarter in the previous year.
Its net income has dropped by 407.8% to $-3M since the same quarter in the previous year.
Finally, its free cash flow grew by 284.0% to $3M since the same quarter in the previous year.
Based on the above factors, CryoLife, Inc gets an overall score of 3/5.
| Sector | Healthcare |
|---|---|
| Industry | Health Care Equipment & Supplies |
| Exchange | NYSE |
| CurrencyCode | USD |
| ISIN | US2289031005 |
| Beta | 0.0 |
|---|---|
| Market Cap | 703M |
| PE Ratio | 425.71 |
| Target Price | 32.44 |
| Dividend Yield | 0.2% |
The fund will invest at least 80% of its net assets in derivatives contracts that utilize the Underlying Leveraged ETF as their reference asset. It is non-diversified.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for CRY using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2026